Hostname: page-component-586b7cd67f-rcrh6 Total loading time: 0 Render date: 2024-11-25T08:15:42.719Z Has data issue: false hasContentIssue false
  • English
  • Français

A Dimensional Approach to the Autism Spectrum

Published online by Cambridge University Press:  07 November 2014

Eric Hollander ,
Charles Cartwright ,
Cheryl M. Wong ,
Concetta M. DeCaria ,
Gina DelGiudice-Asch ,
Monte S. Buchsbaum  and
Bonnie R. Aronowitz
Get access Rights & Permissions [Opens in a new window]

Abstract

Autism is heterogeneous with respect to clinical symptoms and etiology. A significant limitation in research of the neurobiology and treatment of autism has been the lack of attention to this heterogeneity. A dimensional approach to the study of autism is valuable in linking key symptoms to the neurobiology and treatment of the disorder in a clinically meaningful way. In this article, we outline a dimensional approach to the autism spectrum, discuss the three core dimensions of autism and their neurobiology, and review the possible links of serotonin, anterior cingulate gyrus activity, and the immune marker D8/17 to the repetitive behavior/compulsivity dimensions.

Type
Feature Articles
Information
CNS Spectrums , Volume 3 , Issue 3: Autism: Emerging Concensus , March 1998 , pp. 22 - 39
Copyright
Copyright © Cambridge University Press 1998

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.Google Scholar
2.Rutter, M. Language, cognition and autism. In: Katzman, R, ed. Congenital and Acquired Cognitive Disorders. New York, NY: Raven Press; 1979:247–267.Google Scholar
3.Volkmar, FR, Nelson, DS. Seizure disorders in autism. J Am Acad Child Adolesc Psychiatry. 1990;29:127–129.Google Scholar
4.Bailey, A, Le Couteur, A, Gottesman, I, et al.Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med. 1995;25:63–78.CrossRefGoogle ScholarPubMed
5.Le Couteur, A, Bailey, A, Goode, S, et al.A broader phenotype of autism: the clinical spectrum in twins. J Child Psychol Psychiatry. 1996;37:785–801.Google Scholar
6.Bailey, A, Phillips, W, Rutter, M. Autism: towards an integration of clinical, genetic, neuropsychological and neurobiological perspectives. J Child Psychol Psychiatry. 1996;37:89–126.Google Scholar
7.Bolton, P, Macdonald, H, Pickles, A, et al.A case-control family history study of autism. J Child Psychol Psychiatry. 1994;35:877–900.Google Scholar
8.Piven, J, Palmer, P, Jacobi, D, et al.Broader autism phenotype: evidence from a family history study of multipleincidence autism families. Am J Psychiatry. 1997;154:185–190.Google Scholar
9.Wolf, S, Chick, J. Schizoid personality in childhood: a controlled follow-up study. Psychol Med. 1980;10:85–100.Google Scholar
10.Smalley, SL, McCracken, J, Tanguay, P. Autism, affective disorders and social phobia. Am J Med Genet. 1995;60:19–26.Google Scholar
11.McDougle, CJ, Kresch, LE, Goodman, WK, et al.A casecontrolled study of repetitive thoughts and behavior in adults with autistic disorder and obsessive-compulsive disorder. Am J Psychiatry. 1995;152:772–777.Google Scholar
12.Schain, RJ, Freedman, DX. Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children. J Pediatr. 1961;58:315–320.Google Scholar
13.Cook, EK, Leventhal, BL. The serotonin system in autism. Curr Opin Pediatr. 1996;8:348–354.Google Scholar
14.Piven, J, Tsai, G, Nehme, E, et al.Platelet serotonin, a possible marker for familial autism. J Autism Dev Disord. 1991;21:51–59.CrossRefGoogle ScholarPubMed
15.Cook, EH, Charak, DA, Arida, J, et al.Depressive and obsessive-compulsive symptoms in hyperserotonemic parents of children with autistic disorder. Psychiatry Res. 1994;52:25–33.Google Scholar
16.McDougle, CJ, Naylor, ST, Cohen, DJ, et al.Effects of tryptophan depletion in drug-free adults with autistic disorder. Arch Gen Psychiatry. 1996;53:993–1000.Google Scholar
17.Hollander, E, DeCaria, CM, Nitescu, A, et al.Serotonergic function in obsessive-compulsive disorder: behavioral and neuroendocrine responses to oral m-CPP and fenfluramine in patients and healthy volunteers. Arch Gen Psychiatry. 1992;49:21–28.Google Scholar
18.Hollander, E, Prohovnik, I, Stein, DJ. Obsessions and cerebral blood flow during pharmacological challenge with m-CPP. J Neuropsychiatry Clin Neurosci. 1995;7:485–490.Google Scholar
19.McBride, PA, Anderson, GM, Hertzig, ME, et al.Serotonergic responsivity in male young adults with autistic disorder: results of a pilot study. Arch Gen Psychiatry. 1989;14:213–221.Google Scholar
20.Gordon, CT, State, RC, Nelson, JE, et al.A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder. Arch Gen Psychiatry. 1993;50:441–447.Google Scholar
21.Sanchez, LE, Campbell, M, Small, AM, et al.A pilot study of clomipramine in young autistic children. J Am Acad Child Adolesc Psychiatry. 1996;35:537–544.CrossRefGoogle ScholarPubMed
22.Brasic, JR, Barnett, JY, Kaplan, D, et al.Clomipramine ameliorates adventitious movements and compulsions in prepubertal boys with autistic disorder and severe mental retardation. Neurology. 1994;44:1309–1312.Google Scholar
23.Cook, EH, Rowlett, R, Jaselskis, C, et al.Fluoxetine treatment of children and adults with autistic disorder and mental retardation. J Am Acad Child Adolesc Psychiatry. 1992;31:739–745.Google Scholar
24.McDougle, CJ, Naylor, ST, Cohen, DJ, et al.A doubleblind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Arch Gen Psychiatry. 1996;53:1001–1008.Google Scholar
25.Potenza, MN, McDougle, CJ. The role of serotonin in autism-spectrum disorders. CNS Spectrums. 1997;2:25–42.Google Scholar
26.Devinsky, O, Morell, MJ, Vogt, BA. Contributions of the anterior cingulate cortex to behavior. Brain. 1995;118:279–306.Google Scholar
27.Degos, JD, da Fonseca, N, Gray, F, et al.Severe frontal syndrome associated with infarcts of the left anterior cingulate gyrus and the head of the right caudate nucleus: a clinicopathological case. Brain. 1993;116:1541–1548.Google Scholar
28.George, MS, Ketter, TA, Gill, DS, et al.Brain regions involved in recognizing facial emotion or identity: an oxygen-15 PET study. J Neuropsychiatry Clin Neurosci. 1993;5:384–394.Google Scholar
29.Swedo, SE, Shapiro, MB, Grady, CL, et al.Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Arch Gen Psychiatry. 1989;46:518–523.Google Scholar
30.Breiter, HC, Rauch, SL, Kwong, KK, et al.Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder. Arch Gen Psychiatry. 1996;53:595–606.Google Scholar
31.Buchsbaum, MS, Wu, J, Siegel, BV, et al.Effect of sertraline on regional metabolic rate in patients with affective disorder. Biol Psychiatry. 1997;41:15–22.Google Scholar
32.Haznedar, MM, Buchsbaum, MS, Metzger, M, et al.Anterior cingulate gyrus volume and glucose metabolism in autistic disorder. Am J Psychiatry. 1997;154;1047–1050.Google Scholar
33.Zabriskie, JB, Lavernchy, RC, Williams, JR, et al.Rheumatic fever-associated B cell alloantigens as identified by monoclonal antibodies. Arthritis Rheum. 1985;28:1047–1051.Google Scholar
34.Swedo, SE, Leonard, HL, Mittleman, BB, et al.Identification of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections by a marker associated with rheumatic fever. Am J Psychiatry. 1997;154:110–112.Google Scholar
35.Murphy, TK, Goodman, WK, Fudge, MW, et al.B lymphocyte antigen D8/17: a peripheral marker for childhoodonset obsessive-compulsive disorder and Tourette's syndrome? Am J Psychiatry. 1997;154:402–407.Google Scholar
36.Hollander, E, DelGiudice-Asch, G, Simon, L, et al.Repetitive behaviors and D8/17 positivity. Am J Psychiatry. 1997;154:1630. Letter.Google Scholar
37.Insel, TR. A neurobiological basis of social attachment. Am J Psychiatry. 1997;154:726–735.Google Scholar
38.Tribollet, E, Charpak, S, Schmidt, A, et al.Appearance and transient expression of oxytocin receptors in fetal, infant, and peripubertal rat brain studied by autoradiography and electrophysiology. J Neurosci. 1989;9:1764–1773.Google Scholar
39.Pansksepp, J. Commentary on the possible role of oxytocin in autism. J Autism Dev Disord. 1993;23:567–569.Google Scholar
40.Modahl, C, Fein, D, Waterhouse, L. Does oxytocin deficiency mediate social deficits in autism? J Autism Dev Disord. 1992;22:449–451.Google Scholar
41.Leckman, JF, Goodman, WK, North, WG, et al.Elevated cerebrospinal fluid levels of oxytocin in obsessive-compulsive disorder. Arch Gen Psychiatry. 1994;5:782–792.Google Scholar
42.Waterhouse, L, Fein, D, Modahl, C. Neurofunctional mechanisms in autism. Psychol Rev. 1996;103:457–489.Google Scholar
43.Fein, D, Allen, D, Dunn, M, et al.Pitocin induction and autism. Am J Psychiatry. 1997;154:438–439. Letter.Google Scholar